X4 Pharmaceuticals share price logo

X4 Pharmaceuticals

NASDAQ: XFOR

Small Cap

$4.05

+0.01

(+0.25%)

Live

as on

X4 Pharmaceuticals Stock Performance

as on September 4, 2026 at 2:06 am IST

  • Day's Low

    Day's High

    $4.00
    $4.07
    downward going graph

    1.23%

    Downside

    0.49%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.80
    $4.83
    downward going graph

    30.86%

    Downside

    19.26%

    Upside

    downward going graph

X4 Pharmaceuticals share price movements today

Previous Close
$4.04
Open
$4.02
Volume
115.5K
Market Cap
$403.5M
Day's Low - High
$4.00 - $4.07
52 Week Low - High
$2.80 - $4.83

X4 Pharmaceuticals Historical Returns

1 Month Return
+ 2.26 %
3 Month Return
+ 0.74 %
1 Year Return
+ 17.29 %
3 Year Return
-89.56 %
5 Year Return
-97.38 %

X4 Pharmaceuticals Stock Fundamentals & Key Indicators

Check X4 Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$403.5M

EPS (TTM)

-1.2

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.39

Industry PE ratio

-6.724375

PEG Ratio

-0.013917084729238034

EBITDA

-79.5M

Revenue (TTM)

15.8M

Profit Margin

81.22%

Return On Equity TTM

-63.05%

X4 Pharmaceuticals Stock Valuation

Track how X4 Pharmaceuticals P/E has moved over time to understand its valuation trends.

X4 Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-3.94x)

December 31, 2024

Industry (-6.72x)

December 31, 2025

Today (-2.14x)

December 31, 2025

Highest (-0.57x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -2.14x

X4 Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of X4 Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$403.5M-97.38%-3.3981.22%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for X4 Pharmaceuticals Stock including INR - Dollar returns

The X4 Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

X4 Pharmaceuticals investment value today

Current value as on today

₹1,25,199

Returns

₹25,199

(+25.2%)

Returns from X4 Pharmaceuticals Stock

₹16,715 (+16.71%)

Dollar Impact

₹8,484 (+8.48%)

Analyst Recommendation on X4 Pharmaceuticals Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for X4 Pharmaceuticals. Average target price of $11.6

X4 Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on X4 Pharmaceuticals.

What analysts predicted

65.09%UPSIDE

Target Price

$11.6

Current Price

$4.05

Analyzed by

4 Analysts

Target

$11.60

X4 Pharmaceuticals target price $11.6, a slight upside of 65.09% compared to current price of $4.05. According to 4 analysts rating.

Indian Investors' Interest in X4 Pharmaceuticals Stock

Search interest for X4 Pharmaceuticals Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-40% versus previous 30 day period

X4 Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
0
1
28
1
1
2
2
8
Gross Profit
0
0
0
1
23
1
1
2
2
7
Operating Income
-37
-33
-34
-35
-9
-26
-27
-23
-20
-16
EBITDA
-49
93
-33
-36
3
-23
-27
-21
-17
-12
Interest Expense
1
2
2
2
2
2
2
2
2
2
Depreciation
0
0
0
0
0
0
0
0
0
1
Income Before Tax
-51
90
-36
-39
0
-25
-29
-23
-20
-16
Income Tax Expense
0
0
0
0
0
0
0
-
-
0
Net Income
-51
90
-36
-39
0
-25
-29
-23
-20
-16
Net Profit Margin
0.00%
52.40%
45.18%
78.94%
82.63%
74.96%
78.81%
84.93%
77.92%
81.64%

X4 Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
3
-
-
-
2
35
Gross Profit
0
0
0
1
-1
-
-
1
28
Operating Income
-36
-29
-46
-59
-75
-87
-107
-36
-86
EBITDA
-35
-28
-46
-58
-83
-89
-94
-27
-69
Interest Expense
2
0
2
2
3
3
5
8
8
Depreciation
0
0
0
1
1
0
0
0
1
Income Before Tax
-33
-33
-52
-61
-88
-93
-101
-37
-79
Income Tax Expense
-
-
-
0
0
0
0
0
0
Net Income
-33
-33
-52
-62
-88
-93
-101
-37
-79
Net Profit Margin
0.00%
97.06%
0.00%
100.00%
0.00%
0.00%
0.00%
68.83%
82.18%

X4 Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-51
90
-36
-39
0
-25
-29
-23
-20
-16
Operating Cash Flow
-33
-30
-34
-32
-12
-29
-27
-15
-19
-20
Investing Cash Flow
-5
96
-15
-8
-3
23
-28
16
19
-1
Financing Cash Flow
-
20
-
0
-
5
86
146
0
0
Change in Cash
-38
86
-49
-41
-15
-1
30
147
0
-21

X4 Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-33
-52
-62
-88
-93
-101
-37
-79
Operating Cash Flow
-27
-25
-48
-58
-70
-77
-96
-130
-85
Investing Cash Flow
0
-
27
-1
0
0
-14
66
8
Financing Cash Flow
101
6
140
12
74
117
88
20
238
Change in Cash
73
-68
118
-47
2
39
-22
-43
161

Mutual Funds that own X4 Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in X4 Pharmaceuticals.

Funds
Holdings
Shares Held
Fidelity Securities Fund
5.119583%
5075900
VANGUARD INDEX FUNDS
3.435281%
3405970
MORGAN STANLEY INSTITUTIONAL FUND INC
2.353487%
2333406
Fidelity Select Portfolios
1.700207%
1685700
Fidelity Advisor Series VII
1.353347%
1341800

Global Institutional Holdings in X4 Pharmaceuticals

Funds
Holdings
Joseph Edelman
8%
Vanguard
4.18%
iShares
3.03%
Stephen A. Schwarzman
2.71%
Michael Rockefeller
1.01%

Insights on X4 Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 497.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.0% return, outperforming this stock by 123.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, XFOR stock has moved down by -89.6%

About X4 Pharmaceuticals

X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts.
OrganisationX4 Pharmaceuticals
Headquarters61 North Beacon Street, Boston, MA, United States, 02134
IndustryBiotechnology
CEODr. Adam R. Craig M.B.A., M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of X4 Pharmaceuticals

Name

Title

Dr. Richard Peters M.D., Ph.D.

Founder

Dr. Renato T. Skerlj Ph.D.

Founder

Dr. Keith T. Flaherty M.D.

Founder & Member of Corporate Advisory Board

Dr. Adam R. Craig M.B.A., M.D., Ph.D.

Executive Chair

Mr. John P. Volpone M.B.A.

President & COO

Mr. David H. Kirske

CFO, Treasurer & Corporate Secretary

FAQs

What is X4 Pharmaceuticals share price today?

X4 Pharmaceuticals share price today is $4.05 as on . X4 Pharmaceuticals share today touched a day high of $4.07 and a low of $4.00.

What is the 52 week high and 52 week low for X4 Pharmaceuticals share?

X4 Pharmaceuticals share touched a 52 week high of $4.83 on and a 52 week low of $2.80 on . X4 Pharmaceuticals stock price today i.e. is trending at $4.05,which is 16.15% down from its 52 week high and 44.64% up from its 52 week low.

What is X4 Pharmaceuticals's market capitalisation today?

X4 Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in X4 Pharmaceuticals Stock (XFOR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for X4 Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in X4 Pharmaceuticals Shares that will get you 0.3704 shares as per X4 Pharmaceuticals share price of $4.05 per share as on September 3, 2026 at 8:36 pm IST.

What is the minimum amount required to buy X4 Pharmaceuticals Stock (XFOR) from India?

Indian investors can start investing in X4 Pharmaceuticals (XFOR) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in X4 Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on X4 Pharmaceuticals share’s latest price of $4.05 as on September 3, 2026 at 8:36 pm IST, you will get 2.4691 shares of X4 Pharmaceuticals. Learn more about fractional shares .

What are the returns that X4 Pharmaceuticals has given to Indian investors in the last 5 years?

X4 Pharmaceuticals stock has given -97.38% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?